+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Miglitol"

Type 2 Diabetes Market Report 2025 - Product Thumbnail Image

Type 2 Diabetes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Miglitol is a prescription drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as alpha-glucosidase inhibitors, which work by slowing the breakdown of carbohydrates in the intestines, thus reducing the amount of glucose absorbed into the bloodstream. Miglitol is typically used in combination with diet and exercise to help control blood sugar levels. It is also sometimes used in combination with other diabetes medications. Miglitol is a key player in the Endocrine and Metabolic Disorders Drugs market, which includes a range of treatments for conditions such as diabetes, obesity, and thyroid disorders. These drugs are used to help regulate hormones and metabolism, and can be used to treat both acute and chronic conditions. Notable companies in the Miglitol market include Merck & Co., Inc., Sanofi, Novo Nordisk, and Eli Lilly and Company. Show Less Read more